<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01486693</url>
  </required_header>
  <id_info>
    <org_study_id>201109016RC</org_study_id>
    <nct_id>NCT01486693</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis</brief_title>
  <official_title>Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate long term efficacy and safety of topical
      ganciclovir treatment in Cytomegalovirus (CMV) anterior uveitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will enroll 60 patients with positive results of the CMV PCR (polymerase
      chain reaction) from aqueous humor tapping from January 2006 to June 2011. All the patients
      (40 men, 20 women) were immunocompetent and diagnosed as symptomatic CMV infection. Their
      medical records will be reviewed, including demographic data as well as their ophthalmic and
      medical histories.

      The purpose of this study was to evaluate long term efficacy and safety of topical
      ganciclovir treatment in CMV anterior uveitis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anterior chamber inflammation</measure>
    <time_frame>4 weeks after starting treatment</time_frame>
    <description>anterior chamber cell grading based on slit lamp microscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>probability of relapse-free</measure>
    <time_frame>2 years after treatment</time_frame>
    <description>Kaplan-Meier curve of relapse-free probability</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anterior Uveitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        40 men, 20 women, aged 40-80 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with positive results of the CMV PCR (polymerase chain reaction) from aqueous
             humor tapping. All the patients were immunocompetent and diagnosed as symptomatic CMV
             infection.

        Exclusion Criteria:

          -  Patients without positive results of the CMV PCR

          -  Immunocompromised patients with positive results of the CMV PCR
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I-Jong Wang, M.D PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>I-Jong Wang, M.D. PhD</last_name>
    <phone>886-23123456</phone>
    <phone_ext>65729</phone_ext>
    <email>ijong@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I-Jong Wang, M.D. PhD</last_name>
      <phone>886-23123456</phone>
      <phone_ext>65729</phone_ext>
      <email>ijong@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>I-Jong Wang, M.D. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, Inatomi T, Sotozono C, Kawasaki S, Yamasaki K, Mochida C, Ohashi Y, Kinoshita S. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008 Feb;115(2):292-297.e3. Epub 2007 Jul 31.</citation>
    <PMID>17669498</PMID>
  </reference>
  <reference>
    <citation>Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010 Dec;94(12):1648-52. doi: 10.1136/bjo.2009.167767. Epub 2010 Jun 24.</citation>
    <PMID>20576767</PMID>
  </reference>
  <reference>
    <citation>van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007 Jul;114(7):1358-62. Epub 2007 Feb 12.</citation>
    <PMID>17296229</PMID>
  </reference>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>December 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2011</study_first_posted>
  <last_update_submitted>December 5, 2011</last_update_submitted>
  <last_update_submitted_qc>December 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cytomegalovirus</keyword>
  <keyword>uveitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Uveitis, Anterior</mesh_term>
    <mesh_term>Iridocyclitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganciclovir</mesh_term>
    <mesh_term>Ganciclovir triphosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

